Maternal use of recreational drugs and neuroblastoma in offspring: A report from the Children's Oncology Group (United States)

Elizabeth C. Bluhm, Julie Daniels, Bradley H Pollock, Andrew F. Olshan

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objective: To evaluate whether maternal use of recreational drugs around conception and pregnancy influences the risk of childhood neuroblastoma. Methods: Self-reported use of recreational drugs from one month prior to pregnancy until diagnosis was assessed among mothers of 538 children with neuroblastoma (diagnosed 1992-1994 and identified through the Children's Cancer Group and Pediatric Oncology Group) and 504 age-matched controls (identified by random-digit dialing). Odds ratios (OR) and 95% confidence intervals (CI) were estimated using unconditional logistic regression, adjusting for age at diagnosis and household income. Results: Maternal use of any illicit or recreational drug around pregnancy was associated with an increased risk of neuroblastoma in offspring (OR = 1.82, 95% CI: 1.13, 3.00), particularly use of marijuana in the first trimester of pregnancy (OR = 4.75, 95% CI: 1.55, 16.48). Marijuana use in the month before pregnancy did not increase risk. The effect of gestational marijuana exposure was strongest in subjects diagnosed before age one. Evaluation of recreational drugs other than marijuana was limited by infrequent use, and analyses of drug use by fathers were not carried out due to missing data. Conclusions: Maternal recreational drug use and marijuana use during pregnancy were associated with increased risk of neuroblastoma in offspring. Further examination of these drugs and the risk of childhood cancer is warranted.

Original languageEnglish (US)
Pages (from-to)663-669
Number of pages7
JournalCancer Causes and Control
Volume17
Issue number5
DOIs
StatePublished - Jun 2006
Externally publishedYes

Fingerprint

Street Drugs
Neuroblastoma
Cannabis
Mothers
Pregnancy
Odds Ratio
Confidence Intervals
First Pregnancy Trimester
Fathers
Pharmaceutical Preparations
Neoplasms
Age Groups
Logistic Models
Pediatrics

Keywords

  • Case-control studies
  • Marijuana smoking
  • Maternal exposure
  • Neuroblastoma
  • Prenatal exposure delayed effects

ASJC Scopus subject areas

  • Oncology
  • Epidemiology
  • Cancer Research

Cite this

Maternal use of recreational drugs and neuroblastoma in offspring : A report from the Children's Oncology Group (United States). / Bluhm, Elizabeth C.; Daniels, Julie; Pollock, Bradley H; Olshan, Andrew F.

In: Cancer Causes and Control, Vol. 17, No. 5, 06.2006, p. 663-669.

Research output: Contribution to journalArticle

@article{3c4d89b5eaa5424fac38f43ea199d339,
title = "Maternal use of recreational drugs and neuroblastoma in offspring: A report from the Children's Oncology Group (United States)",
abstract = "Objective: To evaluate whether maternal use of recreational drugs around conception and pregnancy influences the risk of childhood neuroblastoma. Methods: Self-reported use of recreational drugs from one month prior to pregnancy until diagnosis was assessed among mothers of 538 children with neuroblastoma (diagnosed 1992-1994 and identified through the Children's Cancer Group and Pediatric Oncology Group) and 504 age-matched controls (identified by random-digit dialing). Odds ratios (OR) and 95{\%} confidence intervals (CI) were estimated using unconditional logistic regression, adjusting for age at diagnosis and household income. Results: Maternal use of any illicit or recreational drug around pregnancy was associated with an increased risk of neuroblastoma in offspring (OR = 1.82, 95{\%} CI: 1.13, 3.00), particularly use of marijuana in the first trimester of pregnancy (OR = 4.75, 95{\%} CI: 1.55, 16.48). Marijuana use in the month before pregnancy did not increase risk. The effect of gestational marijuana exposure was strongest in subjects diagnosed before age one. Evaluation of recreational drugs other than marijuana was limited by infrequent use, and analyses of drug use by fathers were not carried out due to missing data. Conclusions: Maternal recreational drug use and marijuana use during pregnancy were associated with increased risk of neuroblastoma in offspring. Further examination of these drugs and the risk of childhood cancer is warranted.",
keywords = "Case-control studies, Marijuana smoking, Maternal exposure, Neuroblastoma, Prenatal exposure delayed effects",
author = "Bluhm, {Elizabeth C.} and Julie Daniels and Pollock, {Bradley H} and Olshan, {Andrew F.}",
year = "2006",
month = "6",
doi = "10.1007/s10552-005-0580-3",
language = "English (US)",
volume = "17",
pages = "663--669",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "5",

}

TY - JOUR

T1 - Maternal use of recreational drugs and neuroblastoma in offspring

T2 - A report from the Children's Oncology Group (United States)

AU - Bluhm, Elizabeth C.

AU - Daniels, Julie

AU - Pollock, Bradley H

AU - Olshan, Andrew F.

PY - 2006/6

Y1 - 2006/6

N2 - Objective: To evaluate whether maternal use of recreational drugs around conception and pregnancy influences the risk of childhood neuroblastoma. Methods: Self-reported use of recreational drugs from one month prior to pregnancy until diagnosis was assessed among mothers of 538 children with neuroblastoma (diagnosed 1992-1994 and identified through the Children's Cancer Group and Pediatric Oncology Group) and 504 age-matched controls (identified by random-digit dialing). Odds ratios (OR) and 95% confidence intervals (CI) were estimated using unconditional logistic regression, adjusting for age at diagnosis and household income. Results: Maternal use of any illicit or recreational drug around pregnancy was associated with an increased risk of neuroblastoma in offspring (OR = 1.82, 95% CI: 1.13, 3.00), particularly use of marijuana in the first trimester of pregnancy (OR = 4.75, 95% CI: 1.55, 16.48). Marijuana use in the month before pregnancy did not increase risk. The effect of gestational marijuana exposure was strongest in subjects diagnosed before age one. Evaluation of recreational drugs other than marijuana was limited by infrequent use, and analyses of drug use by fathers were not carried out due to missing data. Conclusions: Maternal recreational drug use and marijuana use during pregnancy were associated with increased risk of neuroblastoma in offspring. Further examination of these drugs and the risk of childhood cancer is warranted.

AB - Objective: To evaluate whether maternal use of recreational drugs around conception and pregnancy influences the risk of childhood neuroblastoma. Methods: Self-reported use of recreational drugs from one month prior to pregnancy until diagnosis was assessed among mothers of 538 children with neuroblastoma (diagnosed 1992-1994 and identified through the Children's Cancer Group and Pediatric Oncology Group) and 504 age-matched controls (identified by random-digit dialing). Odds ratios (OR) and 95% confidence intervals (CI) were estimated using unconditional logistic regression, adjusting for age at diagnosis and household income. Results: Maternal use of any illicit or recreational drug around pregnancy was associated with an increased risk of neuroblastoma in offspring (OR = 1.82, 95% CI: 1.13, 3.00), particularly use of marijuana in the first trimester of pregnancy (OR = 4.75, 95% CI: 1.55, 16.48). Marijuana use in the month before pregnancy did not increase risk. The effect of gestational marijuana exposure was strongest in subjects diagnosed before age one. Evaluation of recreational drugs other than marijuana was limited by infrequent use, and analyses of drug use by fathers were not carried out due to missing data. Conclusions: Maternal recreational drug use and marijuana use during pregnancy were associated with increased risk of neuroblastoma in offspring. Further examination of these drugs and the risk of childhood cancer is warranted.

KW - Case-control studies

KW - Marijuana smoking

KW - Maternal exposure

KW - Neuroblastoma

KW - Prenatal exposure delayed effects

UR - http://www.scopus.com/inward/record.url?scp=33646355691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646355691&partnerID=8YFLogxK

U2 - 10.1007/s10552-005-0580-3

DO - 10.1007/s10552-005-0580-3

M3 - Article

C2 - 16633913

AN - SCOPUS:33646355691

VL - 17

SP - 663

EP - 669

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 5

ER -